House To Vote On Orange, Purple Book Bills

By John Wilkerson / May 3, 2019 at 7:01 PM
The House is scheduled to vote the week of May 6 on two minor drug-pricing bills that were part of a legislative package the House Energy & Commerce Committee passed last month. The bills aim to increase the accuracy of documents listing drug and biopharmaceutical patents. The Orange Book Transparency Act ( H.R.1503 ). The bill aims to increase the accuracy of the Orange Book, which lists patents for approved drugs. The Congressional Budget Office estimates it would cost...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.